An international collaborative group of cancer registries and hospitals identified 114 cases of leukemia following ovarian cancer. We investigated the possible etiologic role of chemotherapy, radiotherapy, and other factors, using a case-control study design, with three controls matched to each case of leukemia. Chemotherapy alone was associated with a relative risk of 12 (95 percent confidence interval, 4.4 to 32), as compared with surgery alone, and patients treated with both chemotherapy and radiotherapy had a relative risk of 10 (95 percent confidence interval, 3.4 to 28). Radiotherapy alone did not produce a significant increase in risk as compared with surgery alone. The risk of leukemia was greatest four or five years after chemotherapy began, and the risk was elevated for at least eight years after the cessation of chemotherapy. The drugs cyclophosphamide, chlorambucil, melphalan, thiotepa, and treosulfan were independently associated with significantly increased risks of leukemia, as was the combination of doxorubicin hydrochloride and cisplatin. Chlorambucil and melphalan were the most leukemogenic drugs, followed by thiotepa; cyclophosphamide and treosulfan were the weakest leukemogens, and the effect per gram was substantially lower at high doses than at lower doses. The extent to which the relative risks of leukemia are offset by differences in chemotherapeutic effectiveness is not known.
Source Information
International Agency for Research on Cancer, Lyon, France.
This article has been cited by other articles:
Harrison, B. R., Peters, B. G., Bing, M. R.
(2006). Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.. Am J Health Syst Pharm
63: 1736-1744
[Abstract][Full Text]
Mudie, N. Y., Swerdlow, A. J., Higgins, C. D., Smith, P., Qiao, Z., Hancock, B. W., Hoskin, P. J., Linch, D. C.
(2006). Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study. JCO
24: 1568-1574
[Abstract][Full Text]
Worrillow, L. J., Travis, L. B., Smith, A. G., Rollinson, S., Smith, A. J., Wild, C. P., Holowaty, E. J., Kohler, B. A., Wiklund, T., Pukkala, E., Roman, E., Morgan, G. J., Allan, J. M.
(2003). An Intron Splice Acceptor Polymorphism in hMSH2 and Risk of Leukemia after Treatment with Chemotherapeutic Alkylating Agents. Clin. Cancer Res.
9: 3012-3020
[Abstract][Full Text]
Metayer, C., Curtis, R. E., Vose, J., Sobocinski, K. A., Horowitz, M. M., Bhatia, S., Fay, J. W., Freytes, C. O., Goldstein, S. C., Herzig, R. H., Keating, A., Miller, C. B., Nevill, T. J., Pecora, A. L., Rizzo, J. D., Williams, S. F., Li, C.-Y., Travis, L. B., Weisdorf, D. J.
(2003). Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood
101: 2015-2023
[Abstract][Full Text]
Allan, J. M., Wild, C. P., Rollinson, S., Willett, E. V., Moorman, A. V., Dovey, G. J., Roddam, P. L., Roman, E., Cartwright, R. A., Morgan, G. J.
(2001). Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc. Natl. Acad. Sci. USA
10.1073/pnas.191211198v1
[Abstract][Full Text]
Sanderson, B. J.S., Johnson, K. J., Henner, W.D.
(2001). Induction of mutant lymphocytes in cyclophosphamide- and chlorambucil-treated patients. Mutagenesis
16: 197-202
[Abstract][Full Text]
Mesnil, M., Yamasaki, H.
(2000). Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1. Cancer Res.
60: 3989-3999
[Abstract][Full Text]
Travis, L. B., Andersson, M., Gospodarowicz, M., van Leeuwen, F. E., Bergfeldt, K., Lynch, C. F., Curtis, R. E., Kohler, B. A., Wiklund, T., Storm, H., Holowaty, E., Hall, P., Pukkala, E., Sleijfer, D. T., Clarke, E. A., Boice, J. D. Jr., Stovall, M., Gilbert, E.
(2000). Treatment-Associated Leukemia Following Testicular Cancer. JNCI J Natl Cancer Inst
92: 1165-1171
[Abstract][Full Text]
Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H.
(2000). Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood
95: 3273-3279
[Abstract][Full Text]
Friedberg, J. W., Neuberg, D., Stone, R. M., Alyea, E., Jallow, H., LaCasce, A., Mauch, P. M., Gribben, J. G., Ritz, J., Nadler, L. M., Soiffer, R. J., Freedman, A. S.
(1999). Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma. JCO
17: 3128-3135
[Abstract][Full Text]
Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., Sturgeon, J., Stovall, M., Storm, H., Clarke, E. A., Boice, J. D., Gospodarowicz, M.
(1999). Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer. NEJM
340: 351-357
[Abstract][Full Text]
Smith, M. A., Rubinstein, L., Anderson, J. R., Arthur, D., Catalano, P. J., Freidlin, B., Heyn, R., Khayat, A., Krailo, M., Land, V. J., Miser, J., Shuster, J., Vena, D.
(1999). Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins. JCO
17: 569-569
[Abstract][Full Text]
Chen, T., Aidoo, A., Mittelstaedt, R. A., Casciano, D. A., Heflich, R. H.
(1999). Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa. Carcinogenesis
20: 269-277
[Abstract][Full Text]
Morrell, M. J.
(1998). Guidelines for the care of women with epilepsy. Neurology
51: S21-S27
[Abstract][Full Text]
Zahn, C. A., Morrell, M. J., Collins, S. D., Labiner, D. M., Yerby, M. S.
(1998). Management issues for women with epilepsy: A review of the literature. Neurology
51: 949-956
[Abstract][Full Text]
Kissel, J. T., Elble, R. J.
(1998). Stiff-person syndrome: Stiff opposition to a simple explanation. Neurology
51: 11-14
[Full Text]
Floeter, M. K., Valls-Sole, J., Toro, C., Jacobowitz, D., Hallett, M.
(1998). Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology
51: 85-93
[Abstract][Full Text]
Lennon, V. A., Kryzer, T. J.
(1998). Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo"). Neurology
51: 327-328
[Full Text]
Tanaka, K., Motomura, M., Nakao, Y., Tanaka, M., Tsuji, S.
(1998). Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo"). Neurology
51: 328-329
[Full Text]
Farlow, M. R., Evans, R. M.
(1998). Pharmacologic treatment of cognition in Alzheimer's dementia. Neurology
51: S36-S44
[Abstract][Full Text]
Tramo, M. J., Loftus, W. C., Stukel, T. A., Green, R. L., Weaver, J. B., Gazzaniga, M. S.
(1998). Brain size, head size, and intelligence quotient in monozygotic twins. Neurology
50: 1246-1252
[Abstract][Full Text]
Rosin, L., DeCamilli, P., Butler, M., Solimena, M., Schmitt, H.-P., Morgenthaler, N., Meinck, H.-M.
(1998). Stiff-man syndrome in a woman with breast cancer: An uncommon central nervous system paraneoplastic syndrome. Neurology
50: 94-98
[Abstract][Full Text]
Grau, A. J., Buggle, F., Becher, H., Zimmermann, E., Spiel, M., Fent, T., Maiwald, M., Werle, E., Zorn, M., Hengel, H., Hacke, W.
(1998). Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: Clinical and biochemical studies. Neurology
50: 196-203
[Abstract][Full Text]
de Lima, M., Strom, S. S., Keating, M., Kantarjian, H., Pierce, S., O'Brien, S., Freireich, E., Estey, E.
(1997). Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work. Blood
90: 4719-4724
[Abstract][Full Text]
Grau, A. J.
(1997). Infection, inflammation, and cerebrovascular ischemia. Neurology
49: S47-S51
[Full Text]
Saiz, A., Arpa, J., Sagasta, A., Casamitjana, R., Zarranz, J. J., Tolosa, E., Graus, F.
(1997). Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology
49: 1026-1030
[Abstract][Full Text]
Murman, D. L., Giordani, B., Mellow, A. M., Johanns, J. R., Little, R.J. A., Hariharan, M., Foster, N. L.
(1997). Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's disease. Neurology
49: 153-161
[Abstract][Full Text]
Floeter, M. K., Civitello, L. A., Everett, C. R., Dambrosia, J., Luciano, C. A.
(1997). Peripheral neuropathy in children with HIV infection. Neurology
49: 207-212
[Abstract][Full Text]
Koller, W. C., Montgomery, E. B.
(1997). Issues in the early diagnosis of Parkinson's disease. Neurology
49: S10-S25
[Abstract][Full Text]
Kumar, R., Maraganore, D. M., Ahlskog, J. E., Rodriguez, M.
(1997). Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone. Neurology
48: 732-735
[Abstract][Full Text]
Cummings, J. L., Kaufer, D.
(1996). Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited. Neurology
47: 876-883
[Abstract][Full Text]
Kennedy, W. R., Wendelschafer-Crabb, G., Johnson, T.
(1996). Quantitation of epidermal nerves in diabetic neuropathy. Neurology
47: 1042-1048
[Abstract][Full Text]
Krakauer, J., Balmaceda, C., Gluck, J. T., Posner, J. B., Fetell, M. R., Dalmau, J.
(1996). Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin. Neurology
46: 1486-1486
[Full Text]
Albers, J. W., Brown, M. B., Sima, A. A.F., Greene, D. A.
(1996). Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: The effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Neurology
46: 85-91
[Abstract][Full Text]
Silbert, P.L., Matsumoto, J. Y., McManis, P.G., Stolp-Smith, K.A., Elliott, B. A., McEvoy, K.M.
(1995). Intrathecal baclofen therapy in stiff-man syndrome: A double-blind, placebo-controlled trial. Neurology
45: 1893-1897
[Abstract][Full Text]
Moll, J.W.B., Antoine, J. C., Brashear, H. R., Delattre, J., Drlicek, M., Dropcho, E. J., Giometto, B., Graus, F., Greenlee, J., Honnorat, J., Jaeckle, K. A., Tanaka, K., Vecht, Ch.J.
(1995). Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: Report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, The Netherlands. Neurology
45: 1937-1941
[Full Text]
Kennedy, W. R., Navarro, X., Sutherland, D. E. R.
(1995). Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology
45: 773-780
[Abstract][Full Text]
Leao, M.
(1995). Valproate as a Cause of Hyperammonemia in Heterozygotes With ornithine-transcarbamylase Deficiency. Neurology
45: 593-594
[Full Text]
Jay, V., Becker, L. E., Otsubo, H., Cortez, M., Hwang, P., Hoffman, H. J., Zielenska, M.
(1995). Chronic encephalitis and epilepsy (Rasmussen's encephalitis): Detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology
45: 108-117
[Abstract][Full Text]
Figueroa, M., Gehlsen, J., Hammond, D., Ondreyco, S., Piro, L., Pomeroy, T., Williams, F., McMillan, R.
(1993). Combination Chemotherapy in Refractory Immune Thrombocytopenic Purpura. NEJM
328: 1226-1229
[Abstract][Full Text]
(1990). LEUKEMIA AFTER CHEMOTHERAPY FOR OVARIAN CANCER. JWatch General
1990: 1-1
[Full Text]
Allan, J. M., Wild, C. P., Rollinson, S., Willett, E. V., Moorman, A. V., Dovey, G. J., Roddam, P. L., Roman, E., Cartwright, R. A., Morgan, G. J.
(2001). Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc. Natl. Acad. Sci. USA
98: 11592-11597
[Abstract][Full Text]
